Literature DB >> 19273566

Symptom management for the adult patient dying with advanced chronic kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group.

C Douglas1, F E M Murtagh, E J Chambers, M Howse, J Ellershaw.   

Abstract

Improvement in end-of-life-care is required for patients dying with chronic kidney disease (CKD). The UK government now recommends that tools such as the Liverpool Care Pathway for the Dying Patient (LCP) be used to enhance the care of those patients dying with CKD. The LCP was originally developed for patients dying with terminal cancer, however has been shown to be transferable to patients dying with heart failure or stroke. On this background, in 2005 a UK National Renal LCP Steering Group was formed. The aim was to determine whether or not the generic LCP was transferable to patients dying with CKD. An Expert Consensus sub-group was established to produce evidence-based prescribing guidelines to allow safe and effective symptom control for patients dying with renal failure. These guidelines were finalised by the Expert Consensus group in August 2007 and endorsed by the Department of Health in March 2008. A literature search on symptom control and end-of-life care in renal failure was performed. A summary of the evidence was presented at a National Steering Group meeting. Opinions were given and provisional guidelines discussed. A first draft was produced and individually reviewed by all members of the Expert Group. Following review, amendments were made and a second draft written. This was presented to the entire National Steering Group and again individual comments were taken into consideration. A third and fourth draft were written and individually reviewed, before the guidelines were finalised by the Expert Consensus group. Patients dying with advanced CKD suffer symptoms similar to patients dying of cancer. The Renal LCP prescribing guidelines aim to control the same symptoms as the generic LCP: pain, dyspnoea, terminal restlessness and agitation, nausea and respiratory tract secretions. The evidence for the production of the guidelines is discussed and how a consensus was reached. A summary of the guidelines is given and the complete guidelines document is available via the Marie Curie Palliative Care Institute, Liverpool website.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273566     DOI: 10.1177/0269216308100247

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  14 in total

1.  [Palliative medicine and advanced incurable illness].

Authors:  J Gaertner; St Simon; R Voltz
Journal:  Internist (Berl)       Date:  2011-01       Impact factor: 0.743

Review 2.  Pain and symptom management in palliative care and at end of life.

Authors:  Diana J Wilkie; Miriam O Ezenwa
Journal:  Nurs Outlook       Date:  2012-09-14       Impact factor: 3.250

Review 3.  Current and emerging treatment options for the elderly patient with chronic kidney disease.

Authors:  Robert G Fassett
Journal:  Clin Interv Aging       Date:  2014-01-15       Impact factor: 4.458

4.  Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy.

Authors:  Stephanie A Brown; Freya C Tyrer; Amy L Clarke; Laetitia H Lloyd-Davies; Andrew G Stein; Carolyn Tarrant; James O Burton; Alice C Smith
Journal:  Clin Kidney J       Date:  2017-07-10

Review 5.  The Liverpool Care Pathway: discarded in cancer patients but good enough for dying nursing home patients? A systematic review.

Authors:  Bettina S Husebø; Elisabeth Flo; Knut Engedal
Journal:  BMC Med Ethics       Date:  2017-08-09       Impact factor: 2.652

6.  Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults.

Authors:  Sabine N van der Veer; Wim van Biesen; Pascale Bernaert; Davide Bolignano; Edwina A Brown; Adrian Covic; Ken Farrington; Kitty J Jager; Jeroen Kooman; Juan F Macías-Núñez; Andrew Mooney; Barbara C van Munster; Eva Topinkova; Nele J A Van Den Noortgate; Gerhard Wirnsberger; Jean-Pierre Michel; Ionut Nistor
Journal:  Int Urol Nephrol       Date:  2016-03-17       Impact factor: 2.370

Review 7.  Supportive Care: Economic Considerations in Advanced Kidney Disease.

Authors:  Rachael L Morton; Manjula Kurella Tamura; Joanna Coast; Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-10       Impact factor: 8.237

Review 8.  The Role of Opioids in Pain Management in Elderly Patients with Chronic Kidney Disease: A Review Article.

Authors:  Sanam Dolati; Faezeh Tarighat; Fariba Pashazadeh; Kavous Shahsavarinia; Saina Gholipouri; Hassan Soleimanpour
Journal:  Anesth Pain Med       Date:  2020-10-20

9.  Kidney disease in disadvantaged populations.

Authors:  Rudolph A Rodriguez; Li-Li Hsiao; J Kevin Tucker; David Pugsley
Journal:  Int J Nephrol       Date:  2012-12-31

10.  Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review.

Authors:  Isabel Dietz; Andrea Schmitz; Ingrid Lampey; Christian Schulz
Journal:  BMC Palliat Care       Date:  2013-01-19       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.